Although the links between GLDs and gut microbiota have been well documented in vitro and in animal models [20, 21], research gaps remain in potential crosstalk between human gut microbiota and GLP-1 and different GLDs, and their treatment responses in type 2 diabetes patients. The gene discussed is GCG; the disease is type 2 diabetes mellitus.